-- Delamanid, discovered and developed by Otsuka, has been filed in Japan for the treatment of multidrug-resistant tuberculosis (MDR-TB), following the application in Europe in 2011. This is the first drug application in Japan seeking an indication for treatment of MDR-TB.
-- According to WHO, tuberculosis is one of the three most common infectious diseases. Every year, approximately 8.7 million people become sick, and nearly 1.4 million people die from TB or TB-related causes. It is estimated that 440,000 new cases of MDR-TB emerge each year, leading to 150,000 deaths annually.
-- Otsuka has been working in the TB field for more than 40 years and in 2011 was recognized as the world’s lead investor in TB drug development.ⁱ Otsuka is driven by the dream to create a novel drug for tuberculosis.

The difficulty faced fighting tuberculosis (TB) in Romania has been highlighted this week in a video produced for Al Jazeera. The short but highly informative news item notes how the dual problem of a lack of adequate funding combined with entrenched social stigma make fighting the disease incredibly difficult.

MUMBAI: For two weeks in January 2012, India coughed and the rest of the world paid attention. Drug-resistant tuberculosis, languishing from a decade of neglect by the Indian Revised National Tuberculosis Control Programme, made headlines in every Indian newspaper and several international ones too.

The World Medical Association announced the creation of a new application for tablet computers that will allow physicians to access a training course on the treatment of multidrug-resistant tuberculosis (MDR-TB).

LONDON, 26 March 2013 (IRIN) - Twenty years ago, tuberculosis (TB) was one of the least glamorous branches of medicine. The cause had long been known, as had the cure, so all that was left was the unromantic slog of reducing the poverty, hunger and overcrowding that fostered the disease, and working out better ways to get patients to comply with the lengthy course of treatment needed to cure it.

CAPE TOWN, 26 March 2013 (IRIN) - South Africa will expand its rollout of GeneXpert tuberculosis (TB) testing machines, which can diagnose TB and drug-resistant TB within 90 minutes, but concerns remain about the capacity to back up this commitment with supplies and treatment.

CAPE TOWN, 28 March 2013 (IRIN) - As researchers consider who might benefit most from the next wave of tuberculosis (TB) vaccines, some argue that we're not doing enough with the vaccine we already have.

The President’s Emergency Plan for AIDS Relief  took a hit while the Global Fund to Fight AIDS, Tuberculosis and Malaria got a boost last week when the House and Senate passed a Continuing Resolution bill to avoid a government shutdown and continue funding the government through Oct. 1, the end of fiscal year 2013. The House voted 318-109 to approve a version of the resolution that was passed by the Senate earlier this month. For the first half of FY 2013, Congress had funded most federal programs at FY 2012 levels, with an end date of March 27.

A group of activists launched the Global Coalition of TB Activists (GCTA), a new network that aims to put communities affected by tuberculosis at the centre of decision making in the fight against TB.

Chevy Chase, MD ––Maintaining adequate levels of vitamin D can help people breathe better and may even protect against tuberculosis (TB), according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).